Table 1: Demographic characteristics of study participants.
|
Demographic factors |
Era |
Total (%) |
|||
|
Pre-vaccine era (%) |
Vaccine era (%) |
||||
|
Sex |
Male |
25 (16.7) |
31(20.7) |
56(37.3) |
|
|
Female |
48(32.0) |
46(30.7) |
94(62.7) |
||
|
Total |
73(48.7) |
77(51.4) |
150(100.0) |
||
|
Age Group (Years) |
0 - 5 |
0(0.0) |
22(14.6) |
22(14.6) |
|
|
6 - 10 |
0(0.0) |
15(10.0) |
15(10.0) |
||
|
11 - 15 |
0(0.0) |
8(5.3) |
8(5.3) |
||
|
16 - 20 |
0(0.0) |
32(21.3) |
3221.3) |
||
|
21 - 25 |
60(40.0) |
0(0.0) |
60(40.0) |
||
|
26 - 30 |
12(8.0) |
0(0.0) |
12(8.0) |
||
|
31& above |
1(0.7) |
0(0.0) |
1(0.7) |
||
|
Total |
|
73(48.7) |
77(51.4) |
150(100.0) |
|
|
HB Vaccination |
Yes |
3(2.0) |
9(6.0) |
12(8.0) |
|
|
No |
70(46.6) |
68(45.3) |
138(92.0) |
||
|
Total |
|
73(48.7) |
77(51.4) |
150(100.0) |
|
|
HB vaccine doses received |
1 Dose |
0(0.0) |
2(1.3) |
2(1.3) |
|
|
2 Doses |
3(2.0) |
4(2.6) |
7(4.7) |
||
|
3 Doses |
0(0.0) |
2(1.3) |
2(1.3) |
||
|
Not Sure |
0(0.0) |
1(0.7) |
1(0.7) |
||
|
None |
70(46.6) |
68(45.3) |
138(92.0) |
||
|
Total |
|
73(48.7) |
77(51.4) |
150(100.0) |
|